This study is currently on hold. The study is designed to characterize the pharmacokinetics of DLM using a model-based...
IMPAACT P1026s, the predecessor of this study, was first approved in 2003. P1026s enrolled over 1000 pregnant/postpartum women,...
The purpose of this study is to develop and assess the efficacy of an integrated strategy that includes feasible and scalable...
A5327 SWIFT-C is a Phase I, open-label, two-cohort clinical trial, in which between 44 and 50 acutely HCV-infected HIV-1...
Objectives: Primary: To develop a highly predictive algorithm that identifies TB patients who will be cured by treatment...
